HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin-Fu Zhou Selected Research

Nerve Growth Factor (NGF)

1/2018The ProNGF/p75NTR pathway induces tau pathology and is a therapeutic target for FTLD-tau.
2/2009Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative.
12/2005Actions of brain-derived neurotrophic factor on spinal nociceptive transmission during inflammation in the rat.
1/2005Treatment of spinal cord injury with co-grafts of genetically modified Schwann cells and fetal spinal cord cell suspension in the rat.
6/2003Lumbar 5 ventral root transection-induced upregulation of nerve growth factor in sensory neurons and their target tissues: a mechanism in neuropathic pain.
3/2002Nerve growth factor, neuropeptides, and mast cells in ultraviolet-B-induced systemic suppression of contact hypersensitivity responses in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin-Fu Zhou Research Topics

Disease

37Alzheimer Disease (Alzheimer's Disease)
11/2023 - 10/2006
14Neuroinflammatory Diseases
01/2022 - 10/2009
9Amyloid Plaque
11/2023 - 03/2009
9Pain (Aches)
01/2022 - 05/2002
8Ischemia
08/2022 - 04/2017
8Ischemic Stroke
08/2022 - 04/2015
7Parkinson Disease (Parkinson's Disease)
10/2022 - 12/2015
7Neoplasms (Cancer)
11/2017 - 02/2013
6Spinal Cord Injuries (Spinal Cord Injury)
10/2022 - 01/2005
6Inflammation (Inflammations)
07/2021 - 12/2005
5Cognitive Dysfunction
01/2022 - 03/2009
5Hypoxia (Hypoxemia)
08/2021 - 04/2015
5Huntington Disease (Huntington's Disease)
01/2020 - 01/2009
5Stroke (Strokes)
10/2019 - 08/2016
4Brain Ischemia (Cerebral Ischemia)
10/2019 - 04/2017
4Hyperalgesia
01/2014 - 06/2003
3Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 11/2017
3Brain Injuries (Brain Injury)
06/2021 - 01/2019
3Gliosis
04/2018 - 10/2009
3Bone Fractures (Bone Fracture)
03/2018 - 07/2006
3Traumatic Brain Injuries (Traumatic Brain Injury)
01/2018 - 07/2014
3Glioma (Gliomas)
07/2015 - 08/2013
3Neuralgia (Stump Neuralgia)
06/2006 - 05/2002
2Cerebral Infarction
08/2022 - 10/2019
2Hypertrophy
04/2022 - 01/2014
2Atrophy
01/2022 - 11/2014
2Body Weight (Weight, Body)
01/2022 - 01/2014
2Mood Disorders (Mood Disorder)
01/2021 - 11/2016
2Salter-Harris Fractures
11/2018 - 07/2006
2Neuroblastoma
10/2018 - 01/2018
2Alcoholism (Alcohol Abuse)
01/2018 - 01/2017
2Pancreatitis
01/2018 - 08/2016
2Genomic Instability
01/2016 - 02/2009
2Hypersensitivity (Allergy)
01/2016 - 09/2011
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2022
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2022
1Chronic Disease (Chronic Diseases)
04/2022
1Diabetic Cardiomyopathies
04/2022
1Depressive Disorder (Melancholia)
01/2022
1Insulin Resistance
01/2022
1Obesity
01/2022
1Rheumatoid Arthritis
01/2022
1Motor Neuron Disease (Primary Lateral Sclerosis)
12/2021
1Frontotemporal Dementia (Semantic Dementia)
12/2021
1Nervous System Diseases (Neurological Disorders)
11/2021

Drug/Important Bio-Agent (IBA)

25Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 01/2005
21Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2006
18Amyloid beta-PeptidesIBA
12/2021 - 10/2006
13Amyloid (Amyloid Fibrils)IBA
11/2023 - 02/2009
9Nerve Growth Factors (Neurotrophins)IBA
10/2022 - 06/2003
9sortilinIBA
10/2019 - 06/2013
7EdaravoneIBA
08/2022 - 04/2015
6AntibodiesIBA
01/2021 - 03/2002
6Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
07/2019 - 02/2013
6Nerve Growth Factor (NGF)IBA
01/2018 - 03/2002
5LipopolysaccharidesIBA
01/2022 - 10/2019
4Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2022 - 01/2016
4CytokinesIBA
01/2022 - 04/2018
4Free Radical ScavengersIBA
12/2021 - 04/2015
4EnzymesIBA
01/2021 - 10/2015
4brain-derived neurotrophic factor precursorIBA
01/2021 - 11/2006
3Peptides (Polypeptides)IBA
11/2023 - 10/2012
3CurcuminIBA
01/2022 - 02/2009
3Neuroprotective AgentsIBA
04/2021 - 01/2017
3scutellarinIBA
01/2021 - 04/2018
3Therapeutic UsesIBA
01/2021 - 03/2008
3Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2018 - 08/2016
3nafamostatIBA
01/2018 - 08/2016
2Caspase 3 (Caspase-3)IBA
08/2022 - 01/2018
2Streptozocin (Streptozotocin)FDA Link
01/2022 - 08/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2019
2Messenger RNA (mRNA)IBA
01/2022 - 07/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2019
2Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
07/2021 - 12/2015
2Recombinant ProteinsIBA
03/2021 - 01/2020
2Panax notoginsenoside saponin Rb1IBA
10/2019 - 01/2018
2Nimodipine (Modus)FDA LinkGeneric
10/2019 - 04/2017
2ginsenoside Rb1IBA
10/2019 - 04/2017
2RotenoneIBA
01/2019 - 12/2015
2CopperIBA
10/2018 - 01/2018
2MetalsIBA
10/2018 - 01/2018
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2016 - 09/2011
2Morphine (MS Contin)FDA LinkGeneric
01/2014 - 01/2010
2Neutralizing AntibodiesIBA
11/2010 - 06/2003
2Grape Seed ExtractIBA
02/2009 - 01/2009
2PolyphenolsIBA
02/2009 - 01/2009
1Vesicle-Associated Membrane Protein 2 (VAMP2)IBA
08/2022
1Free RadicalsIBA
04/2022
1CollagenIBA
04/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
04/2022
1Hormones (Hormone)IBA
01/2022
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022
1hyperosideIBA
12/2021

Therapy/Procedure

7Therapeutics
11/2023 - 01/2010
3Transplantation
11/2021 - 07/2014
3Axotomy
06/2006 - 05/2002
2Oral Administration
12/2021 - 04/2015
2Cell- and Tissue-Based Therapy (Cell Therapy)
11/2021 - 01/2018
2Immunotherapy
01/2010 - 03/2009